+
Vet Pharmacovigilance : Experiences in Horses
EMA London FVE Nov 2016
+ Vet Pharmacovigilance : Experiences in Horses EMA London FVE - - PowerPoint PPT Presentation
+ Vet Pharmacovigilance : Experiences in Horses EMA London FVE Nov 2016 + The Horse : center of a unique world + Working animal Transportation Field work Money maker Equine industry High level sport Gambling The
EMA London FVE Nov 2016
Working animal Transportation Field work Money maker Equine industry High level sport Gambling Leisure God Food producer MANY DESTINATIONS
Food animal Meat producer Breeders, slaughters, butchers,
consumers…, Vets
Specialized but Opened industry Origin traceability Minor species FOOD ANIMAL
Drug availability Market authorizations European / International market Medical knowledge Vet Responsability Medical challenge Vet competition Horses value Legislation LMR Cascade Antibiotics EL Exclusion ‘Science’ Clients Dreams MINOR SPECIES VET CHALLENGES
3545 vet answers 668 France Horses 5% Side effects Lack of efficacy
2015 2015
3190 declarations side effects 90% by vets 83% small animals Horses <3% 3857 declarations – 98/horses SA 81%>BV 9%>Horses 2,5% Species #2 (#1=cats) 1 declaration /8000 horses
2013 2015
0.1 0.2 0.3 0.4 0.5
ANMV 2015 declarations
98 declarations side effects 44 important 22 deaths 657 declarations 1051 horses 349 imp 209 deaths
2015 10 years : 2005 - 2015
10 20 30 40 50 60 70
Equine side effects reported %
50 100 150 200 250
Imp equine reports/category
Imp Non imp
133 drugs 5 ‘top categories’ 214 drugs 5 ‘top categories’
2015 10 years : 2005 - 2015
Vaccines 33% Anesth /NS 31% AI 9% AB 8% Dewormers 8% Others 11%
Drug category 2015
Vaccines 27% Anesth /NS 18% AI 10% AB 15% Dewormers 16% Others 14%
Drug category 2005-2015
133 drugs 5 ‘top categories’ 214 drugs 5 ‘top categories’
2015 10 years : 2005 - 2015
10 20 30 40 50 60 Vaccines Anesth /NS AI AB Dewormers Others 2015 2005-2015
73 vets / 24h 69% = pure equine practice Time in practice From 2 to >30 years
Nov 2016 Nov 2016
69% 8% 10% 8% 5%
Equine practice %
100% 75-90% 50-75% 25-50% <20% 2--5 6--10 11--15 15--20 21--25 26--30 >30 10 20 11 10 8 6 8
Years of experience
What for ? Side effects 70% Mortality 31% Lack of efficacy 23% Where to declare ? Industry 43% ANMV 28%
Nov 2016 Nov 2016
Mortality 31% Lack of efficacy 23% Availability 4% Side effects 36% Price report 1% Sales practices 5%
Pharmacovigilance
10 20 30 40 50 Industry Centrale DGAL ANMV AVEF SNGTV CNITV Ordre
Where to declare
Experience of drug problem Yes = 64% Nb of declarations Yes = 57%
Nov 2016 Nov 2016
YES 89% NO 11%
Drug problem
no, never 41% yes, 1 time 28% yes, 2 - 5 times 27% yes, >5 times 4%
Nb of declarations
Drugs categories AB = 35% Vaccines = 19% AI = 14% Anesthetics = 9%
Nov 2016 Nov 2016
5 10 15 20 25 30 35
Drug category
60 molecules reported Top 6 drugs Penicillin
10/60
Critical AB
7/60
Biphosphonates
7/60
Anesthetics
6/60
Herpes vaccines
5/60
Imidocarbe
4/60 Nov 2016 Nov 2016
Peni 26% Critical AB 18% Biphosphonates 18% Anesth 15% Herpes vaccine 13% Imidocarbe 10%
Top 6 drugs
Comments by vets Lack of answer back Too much time to report
Nov 2016 Nov 2016
YES 41% NO 59%
Answer back
In Practice NOW
More reports by vets
Help by tecnical associations? Scientific papers Save + more drugs / horses
FUTURE
Reports by vets
Time to report Increasing interest Responsability Out of label drug uses …
Horse’s welfare Vet position Public health
Claire Scicluna